Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Celsee, IncellDx to Commercialize Assays After Cancer Study Collaboration

Celsee, IncellDx to Commercialize Assays After Cancer Study Collaboration

Jan 11, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Celsee said today that it has entered a co-commercialization agreement with IncellDx for several products, including a 20-marker lung cancer genomics and proteomics panel, a CTC-based screening test for breast, colorectal, prostate, and other cancers, and a cell-based NIPT assay.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Move Away From Basic Research?

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose Dies

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

Flush the System

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

PLOS Papers on Malaria in Southeast Asia, Yellow Fever in Brazil, Dengue Virus Genotyping

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.

What's Popular?

In Business News

  1. Illumina Q2 Revenues Drop 25 Percent

  2. Blackstone to Acquire Ancestry for $4.7B

  3. Rakuten Medical Sues Illumina Over Trademark Dispute

  4. Natera Files Additional Patent Infringement Lawsuit Against ArcherDx

  5. Guardant Health Q2 Revenues Rise 23 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.